↓ Skip to main content

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis

Overview of attention for article published in Arthritis Research & Therapy, May 2021
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
Published in
Arthritis Research & Therapy, May 2021
DOI 10.1186/s13075-021-02529-4
Pubmed ID
Authors

Hubert de Boysson, Maelle Le Besnerais, Félix Blaison, Aurélie Daumas, Pierre-André Jarrot, François Perrin, Nathalie Tieulié, Alexandre Maria, Pierre Duffau, Bruno Gombert, Maxime Samson, Olivier Espitia, Marc Lambert, Arsène Mékinian, Achille Aouba

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 20%
Unspecified 1 5%
Other 1 5%
Student > Bachelor 1 5%
Student > Doctoral Student 1 5%
Other 2 10%
Unknown 10 50%
Readers by discipline Count As %
Medicine and Dentistry 3 15%
Unspecified 1 5%
Business, Management and Accounting 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Nursing and Health Professions 1 5%
Other 1 5%
Unknown 12 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2021.
All research outputs
#20,313,890
of 25,830,657 outputs
Outputs from Arthritis Research & Therapy
#2,848
of 3,416 outputs
Outputs of similar age
#330,634
of 459,792 outputs
Outputs of similar age from Arthritis Research & Therapy
#38
of 47 outputs
Altmetric has tracked 25,830,657 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,416 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,792 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.